10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q1 2018

Filing Information

Form Type	10-Q
Accession Number	`0001564590-18-018106`
Period End Date	20180630
Filing Date	20180731
Fiscal Year	2018
Fiscal Period	Q1
XBRL Instance	tyme-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 20 Cash Flow Statement 34 Stockholders Equity 11

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Prepaid rent	`PrepaidRent`	$242.75K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$787.37K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$732.55K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$23.47M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$29.71M	USD	Point-in-time
Property and equipment, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$16.41K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Property and equipment, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$3.24K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsNoncurrent`	$1.31M	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsNoncurrent`	$1.31M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid rent, net of current portion	`PrepaidRentNoncurrent`	$283.21K	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$31.02M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$25.07M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	101.23M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	101.23M	shares	Point-in-time
Accounts payable and other current liabilities (including $362,000 and $384,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.72M	USD	Point-in-time
Accounts payable and other current liabilities (including $362,000 and $384,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.82M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.25M	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$269.32K	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$480.09K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.99M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.55M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.55M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.99M	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 101,226,479 issued and outstanding at June 30, 2018 and March 31, 2018	`CommonStockValue`	$10.12K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 101,226,479 issued and outstanding at June 30, 2018 and March 31, 2018	`CommonStockValue`	$10.12K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$81.63M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$79.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-59.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-52.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$26.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$22.09M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$25.07M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$31.02M	USD	Point-in-time

Income Statement 20 line items

Line Item	Tag	Value	Unit	Period
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$400.00K	USD	1 Quarter
Revenues	`SalesRevenueNet`	-	USD	1 Quarter
Revenues	`SalesRevenueNet`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$406.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.26M	USD	1 Quarter
General and administrative (including $400,000 and $406,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.71M	USD	1 Quarter
General and administrative (including $400,000 and $406,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$1.92M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.72M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.19M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-6.72M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.19M	USD	1 Quarter
Other income	`NonoperatingIncomeExpense`	$315.62K	USD	1 Quarter
Interest expense	`InterestExpense`	$3.63K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.87M	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	101.23M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.26M	shares	1 Quarter

Cash Flow Statement 34 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-6.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.87M	USD	1 Quarter
Depreciation	`Depreciation`	$1.07K	USD	1 Quarter
Depreciation	`Depreciation`	$2.37K	USD	1 Quarter
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$2.34M	USD	1 Quarter
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$1.30M	USD	1 Quarter
Gain on remeasurement of derivative liability	`DerivativeGainLossOnDerivativeNet`	$315.62K	USD	1 Quarter
Prepaid rent	`IncreaseDecreaseInPrepaidRent`	$525.97K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.05M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$54.82K	USD	1 Quarter
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-99.42K	USD	1 Quarter
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$191.22K	USD	1 Quarter
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.25M	USD	1 Quarter
Net cash used in operating expenses	`NetCashProvidedByUsedInOperatingActivities`	$-2.75M	USD	1 Quarter
Net cash used in operating expenses	`NetCashProvidedByUsedInOperatingActivities`	$-6.31M	USD	1 Quarter
Purchase of property & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.54K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-15.54K	USD	1 Quarter
Insurance note payments	`InsuranceNotePayments`	$210.77K	USD	1 Quarter
Proceeds from private placement offering of common stock and warrants, net of issuance costs	`ProceedsFromIssuanceOfPrivatePlacement`	$2.60M	USD	1 Quarter
Proceeds from collection of stock subscription receivable	`ProceedsFromCollectionOfStockSubscriptionReceivable`	$175.00K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-210.77K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.77M	USD	1 Quarter
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$18.78K	USD	1 Quarter
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-6.54M	USD	1 Quarter
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$22.44M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$10.50M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$22.44M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$10.50M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Interest	`InterestPaidNet`	$3.63K	USD	1 Quarter
Derivative liability associated with the price protection feature of shares of common stock issued	`NonCashFairValueofDerivativeLiability`	$11.79K	USD	1 Quarter

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.47M	USD	Point-in-time
Balance, at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$22.09M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.34M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.87M	USD	1 Quarter
Balance, at end	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.47M	USD	Point-in-time
Balance, at end	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$22.09M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.